Governance

Lyonbiopôle governance: a collective, complementary international-scale process, managed by a versatile team

As a result of the cluster building process, the Lyonbiopôle association brings together players, directly or potentially involved in R&D projects, that make the region’s firms and stakeholders even stronger.

The Lyonbiopôle association was created on November 8, 2005 during the founding general assembly, at which the members of the Board of Directors and Technical Group were named. These two bodies feature representatives from major groups, SMBs, start-ups, training centers and research centers or laboratories that are founding members of the association.

The Board of Directors

Lyonbiopôle’s Board is headed by Philippe Archinard, Managing Director of Transgene and Scientific Director of Mérieux Alliance. He was named as the successor to Docteur Christophe Mérieux on October 5, 2006.

• 6 firms represented by their managers :
  • bioMérieux - Philippe Archinard, Scientific Director of Mérieux Alliance, represents bioMérieux
  • sanofi pasteur - Jacques Berger, Deputy Managing Director
  • Merial SAS - Jean-Louis Crosia, President
  • Becton Dickinson France SAS- Christian Seux, President
  • Alizé Pharma - Thierry Abribat, co-Founder & President
  • Protein'eXpert - Tristan Rousselle, Chief Executive Officer

• 4 technical institutes
  • Inserm - André Syrota, Managing Director
  • University Claude Bernard Lyon 1 - Jean-François Mornex, Vice President
  • Mérieux Foundation - Benoît Miribel, Director
  • CEA, Jean Chabbal

Local authorities are "permanent guests" on the Board:

• Greater Lyon - Lionel Martinez
• Rhône-Alpes Region – Henri Montès, Research and Innovation Division
• Grenoble Alpes Métropole – Jacques Chevallier, Director of Economic Development.
• DRIRE Rhône Alpes - Hedi Ben Brahim 

The Technical Group

The Board of Directors created a Technical Group whose roles include:

• 1. Tracking and reporting on Lyonbiopôle’s activities, in particular R&D projects and multi-disciplinary and joint actions.
• 2. Analyzing R&D projects and proposing that the Board grant them the cluster label, while ensuring that the projects are consistent with Lyonbiopôle’s strategy.
• 3. 3. Proposing strategies in order to bring in additional funding for Lyonbiopôle’s projects and joint actions.

The Technical Group has 8 members:

• 5 firms
  • bioMerieux - Michel Jolivet, Research Director, New Markers Department
  • sanofi pasteur - Marie José Quentin-Millet, Research and Development Division
  • Merial - Jean-Christophe Audonnet, Director, Exploratory Research
  • Becton Dickinson - Philippe Laurent, Vice President, Medical Affairs
  • Imaxio S.A. - Michael Courtney, President
  • DiagnoSwiss -  Joël Rossier, Scientific Director

• 3 technical institutes
  • CEA - Thierry Vernet 
  • CEA/Leti - Christine Peponnet
  • Lyon Civil Hospitals - Charles Dumontet
  • IFR Biosciences - Chantal Rabourdin-Combe
  • Institut Pasteur - Noël Tordo

Lyonbiopôle’s management team

The Board of Directors and Technical Group are supported by a small, flexible management team entrusted with 4 missions:

1. Initiating and supporting the set-up of multi-partner R&D projects and following up on them throughout their deployment
2. Bringing in human and financial resources for the cluster’s projects
3. Coordinating special events and communication between the firms and technical institutes
4. Handling the promotion of Lyonbiopôle, its member firms and institutes and its R&D projects

The team includes 6 permanent members:

• Yves Laurent, Director General
• Bernard Mandrand, Scientific Director
• Isabelle Scarabin Barbelet, Development and International Director
• Claudia Chagneau, Projects manager
• Valérie Four, Personal Assistant.
• Audrey Guilbert, administrative and accounting

For its media/communications needs, Lyonbiopôle relies on outside expertise, from